Swiss All Share Index
17.970,97
PKT
-10,34
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.15 | Richemont buy | Citigroup Corp. | |
| 06.11.15 | Zurich Insurance Outperform | BNP PARIBAS | |
| 06.11.15 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 06.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.11.15 | Zurich Insurance Sell | S&P Capital IQ | |
| 05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.11.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.15 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 04.11.15 | Roche buy | Deutsche Bank AG | |
| 04.11.15 | UBS Hold | Deutsche Bank AG | |
| 04.11.15 | UBS Neutral | Nomura | |
| 04.11.15 | UBS Neutral | JP Morgan Chase & Co. | |
| 04.11.15 | Swiss Re Underperform | Credit Suisse Group | |
| 04.11.15 | Holcim Neutral | UBS AG | |
| 04.11.15 | UBS buy | Société Générale Group S.A. (SG) | |
| 04.11.15 | Nestlé overweight | Morgan Stanley | |
| 03.11.15 | UBS buy | Citigroup Corp. | |
| 02.11.15 | Swiss Re Neutral | UBS AG | |
| 30.10.15 | Swiss Re Underperform | BNP PARIBAS | |
| 30.10.15 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 30.10.15 | Swiss Re buy | Citigroup Corp. | |
| 30.10.15 | UBS Neutral | UBS AG | |
| 29.10.15 | Swiss Re buy | S&P Capital IQ | |
| 29.10.15 | Swiss Re kaufen | DZ-Bank AG | |
| 29.10.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 29.10.15 | Richemont overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Halten | Independent Research GmbH | |
| 28.10.15 | Novartis Outperform | Bernstein Research | |
| 28.10.15 | Novartis buy | Kepler Cheuvreux | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Hold | Deutsche Bank AG | |
| 28.10.15 | UBS Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Equal weight | Barclays Capital | |
| 28.10.15 | Richemont Outperform | BNP PARIBAS | |
| 28.10.15 | Richemont buy | Goldman Sachs Group Inc. | |
| 28.10.15 | Roche buy | UBS AG | |
| 28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | Novartis Hold | S&P Capital IQ | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Richemont overweight | JP Morgan Chase & Co. |